Poseida Therapeutics
Ms. Mylet has over 10 years of finance, accounting, and operational experience with life science companies. She has been at Poseida since June 2015 and served as Poseida’s Senior Vice President, Finance since July 2020. Previously, Ms. Mylet was a controller at HUYA Bioscience International, a company focused on the global development of novel biopharmaceutical products, and an audit manager at Grant Thornton, LLP, where she served life science companies across varying stages of development. She holds a Bachelor of Accountancy from the University of San Diego and is a certified public accountant.
Poseida Therapeutics
Poseida Therapeutics is a clinical-stage biotechnology company translating best-in-class technology into life-saving cell and gene therapies for patients with high unmet medical needs.